Vanina de Verneuil sold $42K of Vir Biotechnology stock
By AlphaYouPublished Form 4
de Verneuil Vanina
Reporting filer
Vanina de Verneuil reported selling 3,750 shares of Vir Biotechnology, Inc. for about $42K ($11.18 a share on average). Form 4 filed Nov 4, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 4, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | de Verneuil Vanina | 2026-11-02 | S | Sale | 1343 | 11.334 | 112,600 | 2 days | Filed terms
|
| Common Stock | de Verneuil Vanina | 2026-11-03 | S | Sale | 2407 | 11.10 | 110,193 | 1 day | Filed terms
|
Common Stock
- Owner
- de Verneuil Vanina
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 1343
- Price
- 11.334
- Following holdings
- 112,600
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1343
- transaction Price Per Share: 11.334
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 112600
- id: F2
- direct Or Indirect Ownership: D
Common Stock
- Owner
- de Verneuil Vanina
- Date
- 2026-11-03
- Code
- S
- Action
- Sale
- Quantity
- 2407
- Price
- 11.10
- Following holdings
- 110,193
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F3
- transaction Shares: 2407
- transaction Price Per Share: 11.10
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 110193
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- de Verneuil Vanina: EVP, General Counsel, Corp Sec.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
- F2: Includes 961 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.
- F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.